United States · Seed startup

Who invested in Nexosome Oncology

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$3.7Mraised across 1 round since 2021, from 1 source

Latest round
Seed, $3.7MNov 2021
Investors
1
See who backed them

The rounds

  1. Nov 2021
    Seed$3.7M

    Source recordedSEC filing: $3.7M sold, first sale Nov 2021

Everyone who backed them

Keyhorse CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Nexosome Oncology as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

VisionTech PartnersAngel networkPer its own site

Quick answers about Nexosome Oncology

Who invested in Nexosome Oncology?

Nexosome Oncology's investors include Keyhorse Capital.

How much has Nexosome Oncology raised?

Nexosome Oncology has raised $3.7M across 1 round since 2021.

When did Nexosome Oncology last raise?

Nexosome Oncology's most recent round was a Seed of $3.7M in Nov 2021.

What was Nexosome Oncology's biggest round?

Its most recent round, $3.7M in Nov 2021, is also its largest on record.

Who backed Nexosome Oncology first?

Nexosome Oncology's first round on record, in Nov 2021, was backed by Keyhorse Capital.

What stage is Nexosome Oncology at?

Nexosome Oncology's latest named round is a Seed, in Nov 2021.

Where is Nexosome Oncology based?

Nexosome Oncology is based in the United States.

Companies like Nexosome Oncology

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.